Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 7,793 shares of the healthcare conglomerate's stock, valued at approximately $4,082,000.

A number of other hedge funds also recently made changes to their positions in UNH. Geode Capital Management LLC grew its position in UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after purchasing an additional 906,365 shares during the period. Norges Bank purchased a new stake in UnitedHealth Group during the 4th quarter valued at $6,375,744,000. Northern Trust Corp boosted its stake in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares during the period. Finally, Franklin Resources Inc. raised its stake in shares of UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after acquiring an additional 861,854 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on UNH shares. HSBC reissued a "reduce" rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Baird R W lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Mizuho dropped their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average price target of $394.43.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $3.06 during trading on Tuesday, reaching $285.20. The stock had a trading volume of 14,233,925 shares, compared to its average volume of 7,873,393. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a market cap of $258.72 billion, a PE ratio of 11.94, a PEG ratio of 1.38 and a beta of 0.45. The business has a fifty day moving average price of $304.47 and a 200-day moving average price of $432.39. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.10%. UnitedHealth Group's payout ratio is presently 37.02%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director directly owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer directly owned 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 over the last ninety days. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.